Advertisement
Screener

Applied Therapeutics, Inc. Operating Cash Flow

Applied Therapeutics, Inc. Operating Cash Flow

Applied Therapeutics, Inc. reported Operating Cash Flow of -$67.38 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-11-13

  • Applied Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$18.40M.
  • Applied Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$20.34M.
  • Applied Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$28.64M.
  • Applied Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$19.47M.
  • Applied Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$84.31M.
  • Applied Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$55.17M.
  • Applied Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$78.09M.
  • Applied Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$90.73M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2025-09-30-$18.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$38.74M
derived: sum of 2 quarters · filed 2025-11-13
-$67.38M
10-Q · filed 2025-11-13
-$86.85M
derived: sum of 4 quarters · filed 2025-11-13
2025-06-30-$20.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
-$48.98M
10-Q · filed 2025-08-13
-$68.45M
derived: sum of 3 quarters · filed 2025-08-13
-$91.78M
derived: sum of 4 quarters · filed 2025-11-13
2025-03-31-$28.64M
10-Q · filed 2025-05-14
-$48.10M
derived: sum of 2 quarters · filed 2025-05-14
-$71.44M
derived: sum of 3 quarters · filed 2025-11-13
-$94.03M
derived: sum of 4 quarters · filed 2025-11-13
2024-12-31-$19.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-$42.80M
derived: sum of 2 quarters · filed 2025-11-13
-$65.39M
derived: sum of 3 quarters · filed 2025-11-13
-$84.31M
10-K · filed 2025-04-15
2024-09-30-$23.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$45.92M
derived: sum of 2 quarters · filed 2025-11-13
-$64.84M
10-Q · filed 2025-11-13
-$81.84M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$22.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
-$41.51M
10-Q · filed 2025-08-13
-$58.51M
derived: sum of 3 quarters · filed 2025-08-13
-$73.24M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$18.91M
10-Q · filed 2025-05-14
-$35.92M
derived: sum of 2 quarters · filed 2025-05-14
-$50.64M
derived: sum of 3 quarters · filed 2025-05-14
-$67.09M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31-$17.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-$31.73M
derived: sum of 2 quarters · filed 2025-04-15
-$48.18M
derived: sum of 3 quarters · filed 2025-04-15
-$55.17M
10-K · filed 2025-04-15
2023-09-30-$14.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$31.18M
derived: sum of 2 quarters · filed 2024-11-07
-$38.17M
10-Q · filed 2024-11-07
-$54.06M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$16.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$23.44M
10-Q · filed 2024-08-07
-$39.34M
derived: sum of 3 quarters · filed 2024-08-07
-$58.73M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31-$6.99M
10-Q · filed 2024-05-09
-$22.88M
derived: sum of 2 quarters · filed 2024-05-09
-$42.27M
derived: sum of 3 quarters · filed 2024-05-09
-$60.67M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$15.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
-$35.28M
derived: sum of 2 quarters · filed 2024-03-06
-$53.68M
derived: sum of 3 quarters · filed 2024-03-06
-$78.09M
10-K · filed 2024-03-06
2022-09-30-$19.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$37.79M
derived: sum of 2 quarters · filed 2023-11-09
-$62.20M
10-Q · filed 2023-11-09
-$89.14M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$18.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$42.81M
10-Q · filed 2023-08-10
-$69.75M
derived: sum of 3 quarters · filed 2023-08-10
-$85.42M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$24.41M
10-Q · filed 2023-05-11
-$51.35M
derived: sum of 2 quarters · filed 2023-05-11
-$67.02M
derived: sum of 3 quarters · filed 2023-05-11
-$92.92M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$26.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
-$42.61M
derived: sum of 2 quarters · filed 2023-03-23
-$68.52M
derived: sum of 3 quarters · filed 2023-03-23
-$90.73M
10-K · filed 2023-03-23
2021-09-30-$15.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$41.57M
derived: sum of 2 quarters · filed 2022-11-09
-$63.79M
10-Q · filed 2022-11-09
-$86.54M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$25.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$48.12M
10-Q · filed 2022-08-12
-$70.87M
derived: sum of 3 quarters · filed 2022-08-12
-$91.56M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31-$22.21M
10-Q · filed 2022-05-12
-$44.96M
derived: sum of 2 quarters · filed 2022-05-12
-$65.66M
derived: sum of 3 quarters · filed 2022-05-12
-$81.57M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$22.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
-$43.44M
derived: sum of 2 quarters · filed 2022-03-10
-$59.35M
derived: sum of 3 quarters · filed 2022-03-10
-$78.21M
10-K · filed 2022-03-10
2020-09-30-$20.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$36.60M
derived: sum of 2 quarters · filed 2021-11-12
-$55.46M
10-Q · filed 2021-11-12
-$67.87M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$15.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$34.77M
10-Q · filed 2021-08-12
-$47.17M
derived: sum of 3 quarters · filed 2021-08-12
-$55.01M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$18.86M
10-Q · filed 2021-05-11
-$31.26M
derived: sum of 2 quarters · filed 2021-05-11
-$39.10M
derived: sum of 3 quarters · filed 2021-05-11
-$48.16M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31-$12.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
-$20.25M
derived: sum of 2 quarters · filed 2021-03-18
-$29.30M
derived: sum of 3 quarters · filed 2021-03-18
-$36.31M
10-K · filed 2021-03-18
2019-09-30-$7.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
-$16.90M
derived: sum of 2 quarters · filed 2020-11-12
-$23.90M
10-Q · filed 2020-11-12
-$29.77M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$9.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
-$16.06M
10-Q · filed 2020-08-11
-$21.93M
derived: sum of 3 quarters · filed 2020-08-11
-$23.95M
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31-$7.00M
10-Q · filed 2020-05-11
-$12.87M
derived: sum of 2 quarters · filed 2020-05-11
-$14.89M
derived: sum of 3 quarters · filed 2020-05-11
-$17.05M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31-$5.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
-$7.89M
derived: sum of 2 quarters · filed 2020-03-13
-$10.05M
derived: sum of 3 quarters · filed 2020-03-13
-$11.18M
10-K · filed 2020-03-13
2018-09-30-$2.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
-$4.18M
derived: sum of 2 quarters · filed 2019-11-13
-$5.31M
10-Q · filed 2019-11-13
2018-06-30-$2.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
-$3.29M
10-Q · filed 2019-08-12
2018-03-31-$1.13M
10-Q · filed 2019-06-21